Navigation Links
UGA, UPR grant license for long-persistence glow materials, in any color
Date:8/17/2009

ndicator has pioneered development of a photoluminescent technology that provides unmatched vibrancy and persistence, as well as an unprecedented palette of colors that can be formulated into a variety of fluids, coating or printing applications. In addition, PI has also discovered how to shift the emission of the base phosphors, through chemistry, into the infrared spectrum, expanding the uses of this technology platform into applications for covert military use and for commercialized anti-counterfeiting/authentication indicators.

Until recently, PI had focused primarily upon developing technologies that merely enhance the performance of phosphor pigments. However, complementing its chemical engineering advancements in these photoluminescent technologies, PI is also now actively engaged in research and development and small-scale manufacturing infrastructure toward the development of next-generation high-persistence phosphors for application in the security, defense, and energy sectors and plans to launch the only domestic plant to manufacture, sell, and distribute long-persistence phosphorescence materials.

"Our work in inventing novel ways to make phosphors (solid state physics) coupled with the revolutionary patented methods that we have developed around formulating phosphors for uses in practical and functional applications (chemistry), is unparalleled," said Robb J. Osinski, Performance Indicator co-founder. "It sets our technology platform far apart from any previous achievements in this field."

"The license granted by UGARF and the University of Puerto Rico enhances our intellectual property portfolio and the capabilities to deliver proprietary and, in many cases, customized photoluminescent-based solutions for a broad array of industrial and consumer applications," he added. "At the same time, it further enables Performance Indicator to import, manufacture, and sell phosphors."

The phosphors were developed under
'/>"/>

Contact: Terry Hastings
thasting@uga.edu
706-542-5941
University of Georgia
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. Peripheral Artery Disease (PAD) Patent Granted to Dimera
2. Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
3. Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist
4. FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Business
5. Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics
6. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
7. Berlin Heart Inc. Receives FDA Orphan Product Development Grant
8. Nanobiotech Center Wins $2.5 Million, 4-Year Grant
9. PTC Therapeutics Receives $2.6 Million in Government Grants
10. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
11. Xceed Meets HTX/CIHR Grant Milestone: Decreasing Sample-Prep Time From Days to Less Than Eight Hours
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UGA, UPR grant license for long-persistence glow materials, in any color
(Date:3/5/2015)... 2015 The next implants made from ... CE mark (European) approval. The CE mark is necessary ... (EFTA) and the European Union. Following the Class IIb ... to implants supplied by the Turkey-based company Osimplant for ... Osimplant's Cervical Expandable Bladed HA PEEK Cage line of ...
(Date:3/4/2015)... March 4, 2015 The UPMC Center for ... Fellows in the Emerging Leaders in Biosecurity Initiative (ELBI). ... in the field of biosecurity, UPMC has selected 28 ... wide array of backgrounds, including biological science, medicine, policy, ... "With the vision and support of the ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and ... the addition of the "Global Biologics and ... offering. , The Global Biologics ... and in-depth study on the current state of ... report provides a basic overview of the industry ...
(Date:3/4/2015)... Calif. , March 4, 2015 ... a specialty pharmaceutical company focused on the development ... of acute and breakthrough pain, today announced that ... financial results after market close on Monday, March ... conference call at 4:30 p.m. Eastern Time (1:30 ...
Breaking Biology Technology:Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 2UPMC Center for Health Security Announces 2015 Emerging Leaders in Biosecurity 3Global Biologics and Biosimilars Industry Report 2015-2020 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3
... Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced ... pixantrone for the treatment of relapsed/refractory diffuse large B-cell ... patient enrollment. The trial, referred to as the PIX-R ... pixantrone plus rituximab to a combination of gemcitabine plus ...
... VEGAS, March 18, 2011 Cord Blood America, ... CBAI ), the umbilical cord blood stem ... saving potential of stem cells to families nationwide and ... to educate and recruit professionals who interact with expectant ...
... Technologies announced today that it has completed a round of ... existing investors and a new strategic partner. The proceeds from ... IG4 four-dimensional image guidance platform of technology. "We ... us to rapidly commercialize the products we are building and ...
Cached Biology Technology:Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 2Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 3Cell Therapeutics Initiates Pixantrone PIX-R Pivotal Trial for Treatment of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma 4Cord Blood America Announces Affiliate Program to Educate on Value of Umbilical Cord Blood Stem Cell Storage 2
(Date:3/3/2015)... Calif. , March 3, 2015 /PRNewswire/ ... leading provider of advanced cryogenic logistics solutions ... including immunotherapies, stem cells, cell lines, clinical ... reproductive medicine, today announced the expansion of ... Research Centers, ("Fred Hutch") Clinical Research ...
(Date:2/25/2015)... 2015  ABC Financial Services (ABC), the leading ... and Fitness Industry, today announced enhancements to their ... latest upgrade includes advances to the agreement section ... via Identity One fingerprint biometrics. The features will ... displays at the International Health, Racquet & Sportsclub ...
(Date:2/23/2015)... OXFORD, Conn. , Feb. 23, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62114357 for ... With this patent, NXT-ID introduces a new groundbreaking payment ... and the payment account may only be accessed if ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3
... has announced the winners of its international travel ... Meeting at the Baltimore Convention Center in Baltimore, ... these awards is to foster and initiate further ... countries experiencing financial difficulties. Recipients of this ...
... nectar containing natural plant toxins but will eat it when ... This means that in areas dominated by these so ... bees struggle to find an alternative food source and so ... under stress, the Newcastle University team believe these toxin-laden nectars ...
... and pests because they seem to thrive everywhere. They have ... the past 50 million years. From deserts to rainforests, ... plentiful source of food, says paleontologist Alisa Winkler, an expert ... their usefulness to scientists as they help shed light on ...
Cached Biology News:Biophysical Society announces winners of 2011 International Travel Awards 2Biophysical Society announces winners of 2011 International Travel Awards 3Biophysical Society announces winners of 2011 International Travel Awards 4Bee challenged -- toxin-laden nectar poses problems for honeybees 2Rodents were diverse and abundant in prehistoric Africa when our human ancestors evolved 2Rodents were diverse and abundant in prehistoric Africa when our human ancestors evolved 3
Schneider's Drosophila - Insect medium...
... Analytical System more than doubles the benefits ... The fast analysis cycles of the standard ... 100% in tandem mode. Difficult separations are ... backflush or heartcut configurations, on-line sample preparation ...
... the gene supplied by a customer. Mutated DNA ... choice to obtain a library of the mutated ... a desired value within 1-20 mutations per kb. ... be restricted to a desired region of a ...
... plasmid DNA preparations are prepared from ... from 1mg to multi-gram scales. Each ... needs, and glycerol stocks are maintained ... clonal selection (Clonal selection includes screening ...
Biology Products: